PRESS RELEASE published on 06/16/2023 at 08:00, 1 year 10 months ago DEFENCE MANUFACTURING OF ACCUTOXTM CGMP FINAL DRUG PRODUCT OPTIMIZATION FOR ITS PHASE I CLINICAL TRIAL AT CITY OF HOPE
PRESS RELEASE published on 06/06/2023 at 08:00, 1 year 10 months ago Defence Therapeutics Inc.: DEFENCE BEGINS TESTING ITS ARM VACCINE AGAINST PANCREATIC CANCER
PRESS RELEASE published on 05/24/2023 at 08:00, 1 year 10 months ago Defence Therapeutics Inc.: BREAKTHROUGH RESULTS: DEFENCE’S ARM VACCINE CURED 100% OF ANIMALS WITH PRE-ESTABLISHED LYMPHOMA
PRESS RELEASE published on 05/02/2023 at 08:00, 1 year 11 months ago Defence Therapeutics Inc.: DEFENCE’S SUCCESFULL ACCUTOXTM PRE-CLINICAL EFFICACY STUDY COMPLETE READY FOR PHASE I IND FILING
PRESS RELEASE published on 04/27/2023 at 08:00, 1 year 11 months ago Defence Therapeutics Inc.: USPTO GRANTS TRADEMARK REGISTRATION FOR DEFENCE THERAPEUTICS®
PRESS RELEASE published on 04/24/2023 at 08:00, 1 year 11 months ago Defence Therapeutics Inc.: DEFENCE GRANTED US PATENT WITH BROAD COVERAGE ON ACCUMTM-BASED VACCINE ENHANCER PLATFORM TECHNOLOGY
PRESS RELEASE published on 04/17/2023 at 08:00, 2 years ago Defence Therapeutics Inc.: DEFENCE'S NOVEL ACCUMTM-mRNA VACCINE NOW ADMINISTERED FOR TESTING ON CANCER
PRESS RELEASE published on 04/11/2023 at 08:00, 2 years ago DEFENCE BREAKTHROUGH: SUCCESSFULLY ENGINEERED ACCUM(TM) -mRNA VACCINE CREATING A NEW VACCINE PLATFORM. THE IN VIVO ACCUM(TM)-mRNA CANCER VACCINE PROGRAM BEGINS
PRESS RELEASE published on 03/28/2023 at 08:00, 2 years ago DEFENCE TO COMPLETE A FINAL PRE-CLINICAL STUDY PRIOR TO IND FILINGS FOR THE ACCUTOXTM PHASE I CANCER TRIAL AT THE CITY OF HOPE NATIONAL MEDICAL CENTER AND BECKMAN RESEARCH INSTITUTE
PRESS RELEASE published on 03/14/2023 at 08:00, 2 years 1 month ago DEFENCE THERAPEUTICS SIGNS COLLABORATION AGREEMENT WITH ORANO TO DEVELOP THE NEXT GENERATION OF TARGETED RADIO-IMMUNOTHERAPY FOR CANCER
Published on 04/23/2025 at 12:00, 47 minutes ago Alta Copper Announces Option Agreement on Arikepay Project
Published on 04/23/2025 at 11:00, 1 hour 47 minutes ago Focus Graphite Advanced Materials Expands C4V Testing Program to Include Cathode Applications Using Spheronization Residue
Published on 04/23/2025 at 09:05, 3 hours 42 minutes ago BioNxt Solutions Prepares for Human Bioequivalence Study For MS
Published on 04/23/2025 at 02:00, 10 hours 47 minutes ago Silver X Reports Significant Operational and Financial Improvement for the Full-Year and Fourth Quarter of 2024
Published on 04/23/2025 at 00:45, 12 hours 2 minutes ago Quebec Precious Metals Announces Shareholder Approval of Arrangement with Fury Gold
Published on 04/23/2025 at 12:00, 47 minutes ago Linde Named One of Ethisphere’s 2025 World's Most Ethical Companies®
Published on 04/23/2025 at 11:45, 1 hour 1 minute ago Delphos Advises on Historic $20 Million Investment for Fintech LendMN to Propel Financial Inclusion in Mongolia
Published on 04/23/2025 at 11:30, 1 hour 17 minutes ago hep solar: successful sale of a 48 MWp portfolio in the USA
Published on 04/23/2025 at 11:06, 1 hour 40 minutes ago Metro Bank Holdings PLC: Publication of 2024 Annual Report and Accounts and Notice of 2025 Annual General Meeting
Published on 04/23/2025 at 08:30, 4 hours 17 minutes ago Aéroports de Paris SA - Modalités de mise à disposition des documents relatifs à l'Assemblée Générale du 15 mai 2025
Published on 04/23/2025 at 08:30, 4 hours 17 minutes ago Aéroports de Paris SA - Terms of availability of the information relating to the General meeting of 15 May 2025
Published on 04/23/2025 at 08:00, 4 hours 47 minutes ago Convocation for an extraordinary general meeting of Gimv on May 26, 2025
Published on 04/23/2025 at 08:00, 4 hours 47 minutes ago Convocation for an extraordinary general meeting of Gimv on May 26, 2025
Published on 04/23/2025 at 08:00, 4 hours 47 minutes ago Oproeping voor een buitengewone algemene vergadering van Gimv op 26 mei 2025
